Abstract
Thrombocytopenia, anasarca, fever, renal dysfunction, and organomegaly (TAFRO) syndrome is an inflammatory disorder with an unclear pathogenesis. We herein report a case of TAFRO syndrome in remission in a patient who experienced recurrent intracranial bleeding despite a normal platelet count and coagulation system. A further investigation suggested the presence of anti-glycoprotein VI (GPVI) autoantibodies in the plasma, which induced platelet dysfunction and bleeding tendency. No new bleeding or relapse of TAFRO syndrome occurred after immunosuppressive therapy was initiated. These findings may help elucidate the autoimmune pathogenesis of TAFRO syndrome.
Original language | English |
---|---|
Pages (from-to) | 1917-1922 |
Number of pages | 6 |
Journal | Internal Medicine |
Volume | 63 |
Issue number | 13 |
DOIs | |
Publication status | Published - 2024 |
Keywords
- anti-glycoprotein VI (GPVI) autoantibody
- GPVI deficiency
- platelet dysfunction
- recurrent cerebral hemorrhaging
- TAFRO syndrome
ASJC Scopus subject areas
- Internal Medicine